Edward Ryder
After completing his PhD on mapping inherited eye diseases in dogs at the Animal Health Trust, Newmarket, Ed Ryder spent eight years as a post-doctoral researcher at the University of Cambridge. Here, he worked as the molecular biology and bioinformatics co-ordinator on projects to create chromosomal deletions and fluorescent protein traps in Drosophila.
Upon moving to the Wellcome Sanger Institute in 2008, Ed took on the role of Senior Scientific Manager in the Mouse Genetics Project, developing and managing the high-throughput genotyping and strain characterisation team as part of the International Mouse Phenotyping Consortium (IMPC).
Ed transferred to LGC Sports and Specialised Analytical Services in 2019 as a Principal Scientist, initiating a research programme for transgene and gene editing detection in Thoroughbred racehorses, sponsored by the British Horseracing Authority.
Ed is co-chair of the Association of Racing Chemists (AORC) gene doping subcommittee, and a member of the International Federation of Horseracing Authorities (IFHA) gene doping subcommittee, who deal with the analysis and regulation of horseracing around the world.
Abstracts this author is presenting: